The landscape of Rx/reimbursement adult incontinence in Slovakia underwent notable changes in 2024 due to regulatory adjustments. From April 2024, new legislation was introduced to refine the prescription process, mandating that doctors indicate the specific level of incontinence on a designated voucher. This measure was intended to streamline the reimbursement process and ensure that patients receive products tailored to their medical needs. Additionally, the financial limit for patients classi...
Euromonitor International's Rx/Reimbursement adult incontinence in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Rx/Reimbursement Adult Incontinence in Slovakia
- Euromonitor International
- March 2025
- List Of Contents And Tables
- RX/REIMBURSEMENT ADULT INCONTINENCE IN SLOVAKIA
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Legislative changes enhance accessibility and affordability
- Leading players prioritise product effectiveness and patient comfort
- Pharmacies remain the dominant distribution channel, ensuring product availability
- PROSPECTS AND OPPORTUNITIES
- Ageing population to drive long-term category growth
- Sustainability and product innovation to shape competition
- E-commerce to expand but remain secondary to pharmacies
- CATEGORY DATA
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2024-2029
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2024-2029
- TISSUE AND HYGIENE IN SLOVAKIA
- EXECUTIVE SUMMARY
- Tissue and hygiene in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retail developments
- What next for tissue and hygiene?
- MARKET INDICATORS
- Table 5 Birth Rates 2019-2024
- Table 6 Infant Population 2019-2024
- Table 7 Female Population by Age 2019-2024
- Table 8 Total Population by Age 2019-2024
- Table 9 Households 2019-2024
- Table 10 Forecast Infant Population 2024-2029
- Table 11 Forecast Female Population by Age 2024-2029
- Table 12 Forecast Total Population by Age 2024-2029
- Table 13 Forecast Households 2024-2029
- MARKET DATA
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2020-2024
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2021-2024
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2019-2024
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2019-2024
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2024
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2024-2029
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2024-2029
- DISCLAIMER
- SOURCES
- Summary 1 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook